K

Kiniksa Pharmaceuticals

223 employees

Kiniksa Pharmaceuticals is developing therapies for inflammatory and autoimmune conditions.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Medical
Biopharma

Date founded

2015

Funding rounds raised

Total raised

$200M

from 1 investors over 1 rounds

K

Kiniksa Pharmaceuticals raised $200M on February 1, 2018

Investors: Sofinnova Ventures, Russia technology fund

FAQ